Oseltamivir Treatment of Influenza in Children.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Influenza in hospitalized pediatric patients in Poland: a retrospective single-center study of the 2023/2024 epidemic season.Archives of medical science : AMS · 2025
   Article
2. The Clinical Effectiveness and Tolerability of Oseltamivir in Unvaccinated Pediatric Influenza Patients during Two Influenza Seasons after the COVID-19 Pandemic: The Impact of Comorbidities on Hospitalization for Influenza in Children.Viruses · 2024
   Observational
3. Factors Associated With Nonprescription of Oseltamivir for Infant Influenza Over 9 Seasons.Journal of the Pediatric Infectious Diseases Society · 2024
   Article
4. Delayed Influenza Treatment in Children With False-Negative Rapid Antigen Test: A Retrospective Single-Center Study in Korea 2016-2019.Journal of Korean medical science · 2022
   Observational
5. SARS-CoV-2: A critical review of its history, pathogenesis, transmission, diagnosis and treatment.Biosafety and health · 2020
   Review
6. COVID-19 therapy: What weapons do we bring into battle?Bioorganic & medicinal chemistry · 2020
   Article
7. Advances in the possible treatment of COVID-19: A review.European journal of pharmacology · 2020
   Review
8. Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements.Life sciences · 2020
   Review
9. A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19).Complementary therapies in clinical practice · 2020
   Review
10. An overview of key potential therapeutic strategies for combat in the COVID-19 battle.RSC advances · 2020
    Review
11. A Revisit to the Research Updates of Drugs, Vaccines, and Bioinformatics Approaches in Combating COVID-19 Pandemic.Frontiers in molecular biosciences · 2020
    Review
12. Clinical trials on drug repositioning for COVID-19 treatment.Revista panamericana de salud publica = Pan American journal of public health · 2020
    Article
13. What are the drugs having potential against COVID-19?Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2020
    Review
14. Study of ongoing registered clinical trials on COVID-19: a narrative review.Sao Paulo medical journal = Revista paulista de medicina
    Review

Corrections and comments

• Comment on
  Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials.2018

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as